IQ4I Research published a report-Drug Discovery Outsourcing (DDO) Global Market – Forecast To 2027

The pharma industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing.
 
BOSTON - Aug. 21, 2019 - PRLog -- This report provides comprehensive insights on the drug discovery outsourcing global market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are AMRI, Aurigene, BioDuro, Charles River Laboratories (CRL), ChemPartner, Eurofins, Evotec, GVK Biosciences, Jubilant, Pharmaron, Selvita S.A., Shanghai Medicilon, Sundia Meditech, Sygnature Discovery, Syngene, TCG Lifesciences and Wuxi Apptec.

This report caters to the need of Contract research organizations, Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the DDO market. The report also provides insights on customer base, number of deals between CRO's and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, revenue per employee of major players, therapeutic area gap analysis and successful research collaboration outcomes of selected CRO's and Sponsors, which are likely to have an impact on the DDO market in the foreseeable future.

Market Analysis:

·       In depth assessment of all segments and sub segments of Drug Discovery Outsourcing (DDO) Global market

·       Regional analysis of drug discovery outsourcing market

·       Market sizing based on molecule type (NCE's and biologics)

·       Emerging trends and strategies with KOL opinions

·       In house pipeline of some of the CRO's

CRO Business:

·       CRO business models

·       Changing CRO business models with recent examples

·       Key performance indicators /metrics of DD

·       Global Pharmaceuticals/Biotech key players R&D expenditure & Intensity

·       Top 50 pharmaceutical companies therapeutic area analysis

Competitor Analysis:

·       DDO Global key players TA Matrix

·       Global snapshot of DDO FTE rates (Chemistry and Biology)

·       Global DDO Key players FTE revenues, Customer base, Deal, TA gap analysis

·       Major outcomes of successful research collaboration of Selected CRO's with Major pharmaceutical/Biotech

Key Players Analysis:

·       Global Key players Overview, Services & capabilities, Therapeutic areas, Business models, Financials and collaborations.

Marketing strategies Analysis:

·       Major conferences attended by key players during 2017 to 2019)

·       Other marketing strategies analysis (Company website rankings)

For more details please visit our website or contact:

Mr. Satish Birudukota,

Website: https://www.iq4i.com

Report link:
https://www.iq4i.com/reports-category/pharmaceuticals/r/130

Email: bd@iq4i.com, satish.birudukota@iq4i.com,

Phone: +91-9886722024, 8147030229,


Media Contact
Mr. Satish Birudukota,
IQ4I Research & Consultancy Pvt. Ltd.,
***@iq4i.com
+91-8147030229
End
Source: » Follow
Email:***@iq4i.com
Tags:#IQ4I
Industry:Health
Location:Boston - Massachusetts - United States
Account Phone Number Verified     Disclaimer     Report Abuse
IQ4I Research & Consultancy Pvt. Ltd PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share